Business Context and Reporting Period
This Form 8-K was filed by Sunshine Heart, Inc. on April 11, 2017. The report discloses a material corporate event under Item 8.01 (Other Events) regarding a senior executive appointment. Note: The request metadata references "Nuwellis, Inc.", but the filing text explicitly identifies the registrant as Sunshine Heart, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and contains no financial statements or quantitative performance data.
Material Changes
The primary material change is the appointment of Jim Breidenstein as Chief Commercial Officer, effective April 24, 2017. In this role, he will oversee all commercial operations for the company.
Management Commentary and Background
- Role Responsibility: Mr. Breidenstein will lead all commercial operations.
- Prior Experience:
- President and Chief Operating Officer at Surgical Theater (medical virtual reality software).
- Senior Vice President of Sales at Cardiovascular Systems, Inc. (peripheral and coronary vascular disease solutions).
- Director of Sales at Kyphon, Inc. (spine surgical instruments, acquired by Medtronic in 2007).
- Education: B.A. in Business Studies from State University of New York College at Buffalo.
Investor Verification Checklist
- Verify the effective start date of Mr. Breidenstein's tenure (April 24, 2017).
- Confirm the scope of "all commercial operations" assigned to the new Chief Commercial Officer.
- Review the company's recent 10-K or 10-Q filings for financial context, as this 8-K contains no financial data.
- Clarify the relationship between the metadata name "Nuwellis, Inc." and the filing registrant "Sunshine Heart, Inc."